A pooled analysis to study trends in exposure to antineoplastic drugs among nurses

Annals of Occupational Hygiene

Volumn 51, Issue 3, 2007, Pages 231-239

  Fransman, Wouter ^a   Peelen, Susan ^a,b   Hilhorst, Simone ^a,c   Roeleveld, Nel ^b   Heederik, Dick ^a   Kromhout, Hans ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Antineoplastic drugs; Cyclophosphamide; Nurses; Occupational exposure; Time trend

Indexed keywords

DRUG PRODUCTS; HEALTH CARE; HEALTH HAZARDS; HEALTH RISKS; BODY FLUIDS; REGRESSION ANALYSIS;

ANTINEOPLASTIC DRUGS; CYCLOPHOSPHAMIDE; GLOVE CONTAMINATION; OCCUPATIONAL EXPOSURE; TIME TRENDS;

OCCUPATIONAL RISKS; NURSING;

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ALKYLATING AGENT;

ARTICLE; CONTAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HAZARD RATIO; HEALTH SURVEY; HUMAN; NETHERLANDS; NURSE; OCCUPATIONAL EXPOSURE; ONCOLOGY WARD; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; URINALYSIS; AMBULATORY CARE; CLINICAL TRIAL; EQUIPMENT; MULTICENTER STUDY; NURSING STAFF; PROTECTIVE CLOTHING; URINE;

ANTINEOPLASTIC DRUGS; CARCINOGENIC EFFECTS; CONTAMINATION LEVELS; CYCLOPHOSPHAMIDE; GENERALIZED ESTIMATING EQUATIONS; OCCUPATIONAL EXPOSURE; SURFACE CONTAMINATIONS; TIME TRENDS;

AMBULATORY CARE; ANTINEOPLASTIC AGENTS, ALKYLATING; CROSS-SECTIONAL STUDIES; CYCLOPHOSPHAMIDE; EQUIPMENT CONTAMINATION; GLOVES, PROTECTIVE; HUMANS; NETHERLANDS; NURSING STAFF, HOSPITAL; OCCUPATIONAL EXPOSURE;

EID: 34447511309     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mel081     Document Type: Article

References (32)

1. Burgaz S, Karahalil B, Bayrak P et al. (1999) Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res; 439: 97-104.
2. Cherrie JW, Semple S, Christopher Y et al. (2006) How important is inadvertent ingestion of hazardous substances at work? Ann Occup Hyg; 50: 693-704.
3. Connor TH, Anderson RW, Sessink PJM et al. (1999) Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health-Syst Pharm; 56: 1427-32.
4. Ensslin AS, Huber R, Pethran A et al. (1997) Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: Urinary excretion and cytogenetics studies. Int Arch Occup Environ Health; 70: 205-8.
5. Falck K, Gröhn P, Sorsa M et al. (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet; 1: 1250-1.
6. Fransman W, Roeleveld N, Peelen S et al. (2007) Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology; 18: 112-9.
7. Fransman W, Vermeulen R, Kromhout H. (2004) Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Ann Occup Hyg; 48: 237-44.
8. Fransman W, Vermeulen R, Kromhout H. (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health; 78: 403-12.
9. Goloni-Bertollo EM, Tajara EH, Manzato AJ et al. (1992) Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int J Cancer; 50: 341-4.
10. Health & Safety Executive (2003) Safe handling of cytotoxic drugs. HSE Information Sheet MISC615. United Kingdom. http://www.hse.gov.uk/.
11. Hilhorst SKM, Miedema EP, Tijssen SCHA et al. (2001) Blootstelling aan cytostatica in ziekenhuizen: Stand der techniek op het gebied van beheersmaatregelen. Den Haag, The Netherlands: Ministry of Social Affairs and Employment.
12. Hornung RW, Reed LD. (1990) Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg; 5: 46-51.
13. Kromhout H, Hoek F, Uitterhoeve R et al. (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg; 44: 551-60.
14. McDevitt JJ, Lees PS, McDiarmid MA. (1993) Exposure of hospital pharmacists and nurses to antineoplastic agents. J Occup Med; 35: 57-60.
15. Meijster T, Fransman W, van Hemmen JJ et al. (2006) A probabilistic assessment of the impact of interventions on the exposure to antineoplastic agents of oncology nurses. Occup Environ Med; 63: 530-7.
16. Milkovic-Kraus S, Horvat D. (1991) Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs. Am J Ind Med; 19: 771-4.
17. Ministry of Social Affairs and Employment (2004) Arboconvenant academische ziekenhuizen. Den Haag, The Netherlands. http://www. arboconvenantacademischeziekenhuizen.nl/.
18. NIOSH-Alert (2004) Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Cincinatti, USA. http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf.
19. Pethran A, Schierl R, Hauff K et al. (2003) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health; 76: 5-10.
20. Pohlová H, Cernà M, Rössner P. (1986) Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs. Mutat Res; 174: 213-7.
21. Rubino FM, Floridia L, Pietropaolo AM et al. (1999) Measurement of surface contamination by certain antineoplastic drugs using high-performance liquid chromatography: applications in occupational hygiene investigations in hospital environments. Med Lav; 90: 572-83.
22. Sardas S, Gök S, Karakaya AE. (1991) Sister chromatid exchanges in lymphocytes of nurses handling antineoplastic drugs. Toxicol Lett; 55: 311-5.
23. Schmaus G, Schierl R, Funck S. (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health-Syst Pharm; 59: 956-61.
24. Selevan SG, Lindbohm ML, Hornung RW, Hemminki K. (1985) A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med; 313: 1173-8.
25. Sessink PJ, van de Kerkhof MC, Anzion RB et al. (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health; 49: 165-9.
26. Sessink PJM, Anzion RBM, van den Broek PHH et al. (1992a) Detection of contamination with anti-neoplastic agents in a hospital pharmacy department. Pharmaceutisch Weekblad; 14: 16-22.
27. Sessink PJM, Boer KA, Scheefhals APH et al. (1992b) Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health; 64: 105-12.
28. Sessink PJM, Scholtes MM, Anzion RBM et al. (1993) Determination of cyclofosfamide in urine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl; 616: 333-7.
29. Stücker I, Caillard JF, Collin R et al. (1990) Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health; 16: 102-7.
30. Waksvik H, Klepp O, Brogger A. (1981) Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep; 65: 607-10.
31. Worksafe Victoria (2003) Handling cytotoxic drugs in the workplace. Victoria, Australia. http://www.workcover.vic.gov.au/.
32. Zeger SL, Liang KY. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics; 42: 121-30.